Eli Lilly's cancer drug gets second approval from US FDA

Eli Lilly's drug Jaypirca has received a second approval from the US FDA for the treatment of chronic lymphocytic leukemia (CLL), adding to its previous approval for mantle cell lymphoma (MCL).

Related Keywords

United Kingdom , ,Novo Nordisk Novob Co Wegovy ,National Institutes Of Health ,National Institutes ,Eli Lilly ,Novo Nordisk ,Fda ,Us Fda ,Leukemia ,Jaypirca ,